These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 38584157)

  • 21. Gasdermins: a dual role in pyroptosis and tumor immunity.
    Yang J; Jiang J
    Front Immunol; 2024; 15():1322468. PubMed ID: 38304430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Expression and Copy Number Variation of Gasdermin (GSDM) Family Members, Pore-Forming Proteins in Pyroptosis, in Normal and Malignant Serous Ovarian Tissue.
    Berkel C; Cacan E
    Inflammation; 2021 Dec; 44(6):2203-2216. PubMed ID: 34091823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Regulation and Modification of GSDMD Signaling in Diseases.
    Li Z; Ji S; Jiang ML; Xu Y; Zhang CJ
    Front Immunol; 2022; 13():893912. PubMed ID: 35774778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gasdermin D triggers cardiolipin-driven mitochondrial damage and pyroptosis.
    Cai Q; Shubhra QTH
    Trends Immunol; 2024 Feb; 45(2):75-77. PubMed ID: 38242759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Mechanistic Understanding of Pyroptosis: The Fiery Death Triggered by Invasive Infection.
    Liu X; Lieberman J
    Adv Immunol; 2017; 135():81-117. PubMed ID: 28826530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crosstalk of HDAC4, PP1, and GSDMD in controlling pyroptosis.
    Xu W; Jin Q; Li X; Li D; Fu X; Chen N; Lv Q; Shi Y; He S; Dong L; Yang Y; Yan Y; Shi F
    Cell Death Dis; 2024 Feb; 15(2):115. PubMed ID: 38326336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyroptosis inhibiting nanobodies block Gasdermin D pore formation.
    Kopp A; Hagelueken G; Jamitzky I; Moecking J; Schiffelers LDJ; Schmidt FI; Geyer M
    Nat Commun; 2023 Dec; 14(1):7923. PubMed ID: 38040708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gasdermin D: A Potential New Auxiliary Pan-Biomarker for the Detection and Diagnosis of Diseases.
    Wan N; Shi J; Xu J; Huang J; Gan D; Tang M; Li X; Huang Y; Li P
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gasdermins: New Therapeutic Targets in Host Defense, Inflammatory Diseases, and Cancer.
    Magnani L; Colantuoni M; Mortellaro A
    Front Immunol; 2022; 13():898298. PubMed ID: 35844522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and structural aspects of gasdermin family pores and insights into gasdermin-elicited programmed cell death.
    Zahid A; Ismail H; Jin T
    Biochem Soc Trans; 2021 Dec; 49(6):2697-2710. PubMed ID: 34812891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gasdermins gone wild: new roles for GSDMs in regulating cellular homeostasis.
    Weindel CG; Ellzey LM; Martinez EL; Watson RO; Patrick KL
    Trends Cell Biol; 2023 Sep; 33(9):773-787. PubMed ID: 37062616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-associated pyroptosis: A new license to kill tumor.
    Kong Q; Zhang Z
    Front Immunol; 2023; 14():1082165. PubMed ID: 36742298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gasdermin D pore-forming activity is redox-sensitive.
    Devant P; Boršić E; Ngwa EM; Xiao H; Chouchani ET; Thiagarajah JR; Hafner-Bratkovič I; Evavold CL; Kagan JC
    Cell Rep; 2023 Jan; 42(1):112008. PubMed ID: 36662620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gasdermin D-Mediated Pyroptosis in Diabetic Cardiomyopathy: Molecular Mechanisms and Pharmacological Implications.
    Liu Z; Chen Y; Mei Y; Yan M; Liang H
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation.
    Hu JJ; Liu X; Xia S; Zhang Z; Zhang Y; Zhao J; Ruan J; Luo X; Lou X; Bai Y; Wang J; Hollingsworth LR; Magupalli VG; Zhao L; Luo HR; Kim J; Lieberman J; Wu H
    Nat Immunol; 2020 Jul; 21(7):736-745. PubMed ID: 32367036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precise Orchestration of Gasdermins' Pore-Forming Function by Posttranslational Modifications in Health and Disease.
    Jiang H; Liu P; Kang J; Wu J; Gong W; Li X; Li Y; Liu J; Li W; Ni C; Liao B; Wu X; Zhao Y; Ren J
    Int J Biol Sci; 2023; 19(15):4931-4947. PubMed ID: 37781519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Insight of Gasdermin Family Driving Pyroptotic Cell Death.
    Ruan J
    Adv Exp Med Biol; 2019; 1172():189-205. PubMed ID: 31628657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSDMD-mediated pyroptosis in retinal vascular inflammatory diseases: a review.
    Xiaodong L; Xuejun X
    Int Ophthalmol; 2023 Apr; 43(4):1405-1411. PubMed ID: 36068399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GSDMD in regulated cell death: A novel therapeutic target for sepsis.
    Ma X; Lin Y; Zhang L; Miao S; Zhang H; Li H; Fu X; Han L; Li P
    Int Immunopharmacol; 2024 Jun; 135():112321. PubMed ID: 38795599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway.
    Evavold CL; Hafner-Bratkovič I; Devant P; D'Andrea JM; Ngwa EM; Boršić E; Doench JG; LaFleur MW; Sharpe AH; Thiagarajah JR; Kagan JC
    Cell; 2021 Aug; 184(17):4495-4511.e19. PubMed ID: 34289345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.